NHS: Drugs
Lords · Question HL9906 · Tabled 24 Jul 2025 · Department of Health and Social Care · Official record
Answered 4 Aug 2025
Question
Asked by Lord Rennard
To ask His Majesty's Government what assessment they have made of adopting reimbursed access at the point of marking authorisation for medicines; and what assessment they have made of the impact of cost-effectiveness appraisals after real world use on the
Answer
Answered by Baroness Merron, 4 Aug 2025
The Government wants National Health Service patients in England to be able to benefit from rapid access to effective new medicines. The National Institute for Health and Care Excellence (NICE) evaluates all new licensed medicines and makes recommendation...